Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 45 AND POTASSIUM CHLORIDE 20MEQ K IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 45 AND POTASSIUM CHLORIDE 20MEQ K IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides a source of calories and is metabolized to carbon dioxide and water, producing energy. Sodium chloride maintains electrolyte balance and osmotic pressure. Potassium chloride replaces potassium for cellular ion exchange and acid-base balance.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion. Dosing is individualized based on fluid, electrolyte, and caloric requirements. Typical adult maintenance dose: 1-3 L/day at a rate of 50-125 mL/hour. Maximum infusion rate: 0.5 g/kg/hour for glucose; potassium infusion rate should not exceed 10 mEq/hour or 200 mEq/day in adults.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
Dextrose: ~15-20 min (rapid uptake into cells). Potassium: ~8-12 h (redistribution half-life ~1 h; terminal elimination depends on renal function, clinical context: prolonged in renal impairment).
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Renal: >95% of dextrose (as CO2 via respiration) and sodium and chloride (with water); potassium excreted renally, ~90% reabsorbed, distal secretion under aldosterone control. Minimal fecal/biliary.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte